BCTX (Briacell Therapeutics Corp. Common Shares) Stock Analysis - SEC Filings

Briacell Therapeutics Corp. Common Shares (BCTX) is a publicly traded Healthcare sector company. As of May 21, 2026, BCTX trades at $3.98 with a market cap of $24.29M and a P/E ratio of -0.06. BCTX moved +9.69% today. Year to date, BCTX is -49.28%; over the trailing twelve months it is -89.10%. Its 52-week range spans $2.98 to $214.50. Rallies surfaces BCTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find BCTX SEC filings?

Rallies organizes BCTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

BCTX Key Metrics

Key financial metrics for BCTX
MetricValue
Price$3.98
Market Cap$24.29M
P/E Ratio-0.06
EPS$-62.19
Dividend Yield0.00%
52-Week High$214.50
52-Week Low$2.98
Volume1.20K
Avg Volume0
Revenue (TTM)$0
Net Income$-26.56M
Gross Margin0.00%

Latest BCTX News

Recent BCTX Insider Trades

  • Lustig Marc bought 902.93K (~$2.00M) on May 14, 2024.
  • Bondarenko Jamieson bought 28.00K (~$128.24K) on Dec 28, 2022.
  • Bondarenko Jamieson bought 22.00K (~$117.70K) on Dec 20, 2022.

BCTX Analyst Consensus

BCTX analyst coverage data. Average price target: $0.00.

Common questions about BCTX

Where can I find BCTX SEC filings?
Rallies organizes BCTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show BCTX 10-K and 10-Q filings?
Rallies organizes BCTX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is BCTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BCTX. It does not provide personalized investment advice.
BCTX

BCTX